EXPRESSION OF ESTROGEN SULFOTRANSFERASE IN MCF-7 CELLS BY CDNA TRANSFECTION SUPPRESSES THE ESTROGEN RESPONSE - POTENTIAL ROLE OF THE ENZYMEIN REGULATING ESTROGEN-DEPENDENT GROWTH OF BREAST EPITHELIAL-CELLS
Ym. Qian et al., EXPRESSION OF ESTROGEN SULFOTRANSFERASE IN MCF-7 CELLS BY CDNA TRANSFECTION SUPPRESSES THE ESTROGEN RESPONSE - POTENTIAL ROLE OF THE ENZYMEIN REGULATING ESTROGEN-DEPENDENT GROWTH OF BREAST EPITHELIAL-CELLS, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 555-560
Estrogen sulfotransferase (EST) is a cytosolic enzyme that catalyzes t
he sulfonation of estrogens at the 3-hydroxyl position by use of 3'-ph
osphoadenosine-5'-phosphosulfate as an activated sulfate donor. Althou
gh largely known and studied as a phase II metabolic enzyme with promi
nent expression in the liver, the high substrate specificity of EST (w
ith a high V-max/K-m value for estrogen) suggests that expression of t
he enzyme in extrahepatic, estrogen target tissues, such as the breast
epithelium, may constitute an effective mechanism for local estrogen
regulation as well. In this study, we have evaluated the physiological
significance of EST expression by cDNA transfection studies with use
of the estrogen-dependent MCF-7 breast cancer cell line as a model sys
tem. We show that expression of EST in MCF-7 cells effectively reduces
the cells' response to physiological concentrations of estradiol (10
nM) by up to 70% as determined in an estrogen-responsive reporter gene
assay. In addition, we demonstrate that expression of EST similarly i
nhibits estrogen-stimulated DNA synthesis and cell proliferation by 21
% and 46%, respectively. (The thymidine incorporation rate was measure
d 3 days after and the cell numbers were counted 8 days after transfec
tion.) These results provide direct evidence for the functional signif
icance of in situ EST expression in the breast epithelium and suggest
that abnormal regulation of the enzyme may have pathological implicati
ons in the development and maintenance of hormone-dependent breast car
cinomas.